pubmed-article:2543285 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2543285 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
pubmed-article:2543285 | lifeskim:mentions | umls-concept:C0005953 | lld:lifeskim |
pubmed-article:2543285 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
pubmed-article:2543285 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:2543285 | lifeskim:mentions | umls-concept:C1579410 | lld:lifeskim |
pubmed-article:2543285 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:2543285 | pubmed:dateCreated | 1989-7-7 | lld:pubmed |
pubmed-article:2543285 | pubmed:abstractText | 3'-Azido-2',3'-dideoxythymidine is known to cause severe anemia and neutropenia. Although these are rare for 2',3'-dideoxycytidine, it frequently impairs thrombocytogenesis. These differential myelossuppressive features correlated well with the in vitro toxicities of the drugs for a megakaryoblastic cell line and for colony formation of erythroid and granulocytic cells. | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:language | eng | lld:pubmed |
pubmed-article:2543285 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2543285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2543285 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2543285 | pubmed:month | Apr | lld:pubmed |
pubmed-article:2543285 | pubmed:issn | 0066-4804 | lld:pubmed |
pubmed-article:2543285 | pubmed:author | pubmed-author:NagaiYY | lld:pubmed |
pubmed-article:2543285 | pubmed:author | pubmed-author:LUNTM RMR | lld:pubmed |
pubmed-article:2543285 | pubmed:author | pubmed-author:InoueTT | lld:pubmed |
pubmed-article:2543285 | pubmed:author | pubmed-author:OguraMM | lld:pubmed |
pubmed-article:2543285 | pubmed:author | pubmed-author:YoshidaSS | lld:pubmed |
pubmed-article:2543285 | pubmed:author | pubmed-author:TomodaYY | lld:pubmed |
pubmed-article:2543285 | pubmed:author | pubmed-author:SaneyoshiMM | lld:pubmed |
pubmed-article:2543285 | pubmed:author | pubmed-author:SaitohHH | lld:pubmed |
pubmed-article:2543285 | pubmed:author | pubmed-author:HottaTT | lld:pubmed |
pubmed-article:2543285 | pubmed:author | pubmed-author:TsushitaKK | lld:pubmed |
pubmed-article:2543285 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2543285 | pubmed:volume | 33 | lld:pubmed |
pubmed-article:2543285 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2543285 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2543285 | pubmed:pagination | 576-9 | lld:pubmed |
pubmed-article:2543285 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:2543285 | pubmed:meshHeading | pubmed-meshheading:2543285-... | lld:pubmed |
pubmed-article:2543285 | pubmed:meshHeading | pubmed-meshheading:2543285-... | lld:pubmed |
pubmed-article:2543285 | pubmed:meshHeading | pubmed-meshheading:2543285-... | lld:pubmed |
pubmed-article:2543285 | pubmed:meshHeading | pubmed-meshheading:2543285-... | lld:pubmed |
pubmed-article:2543285 | pubmed:meshHeading | pubmed-meshheading:2543285-... | lld:pubmed |
pubmed-article:2543285 | pubmed:meshHeading | pubmed-meshheading:2543285-... | lld:pubmed |
pubmed-article:2543285 | pubmed:meshHeading | pubmed-meshheading:2543285-... | lld:pubmed |
pubmed-article:2543285 | pubmed:meshHeading | pubmed-meshheading:2543285-... | lld:pubmed |
pubmed-article:2543285 | pubmed:meshHeading | pubmed-meshheading:2543285-... | lld:pubmed |
pubmed-article:2543285 | pubmed:year | 1989 | lld:pubmed |
pubmed-article:2543285 | pubmed:articleTitle | In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus. | lld:pubmed |
pubmed-article:2543285 | pubmed:affiliation | Department of Obstetrics and Gynecology, Nagoya University School of Medicine, Japan. | lld:pubmed |
pubmed-article:2543285 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2543285 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2543285 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2543285 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2543285 | lld:pubmed |